98 related articles for article (PubMed ID: 30446846)
21. 31P NMR studies of cultured human tumor cells. Influence of pH on phospholipid metabolite levels and the detection of cytidine 5'-diphosphate choline.
Kuesel AC; Graschew G; Hull WE; Lorenz W; Thielmann HW
NMR Biomed; 1990 Apr; 3(2):78-89. PubMed ID: 2390457
[TBL] [Abstract][Full Text] [Related]
22. Probing the PI3K/Akt/mTor pathway using
Phyu SM; Tseng CC; Fleming IN; Smith TA
Sci Rep; 2016 Nov; 6():36544. PubMed ID: 27811956
[TBL] [Abstract][Full Text] [Related]
23. GSK3 promotes arsenite-induced apoptosis via facilitation of mitochondria disruption.
Watcharasit P; Thiantanawat A; Satayavivad J
J Appl Toxicol; 2008 May; 28(4):466-74. PubMed ID: 17849503
[TBL] [Abstract][Full Text] [Related]
24. Glycogen synthase kinase 3 involvement in the excessive proinflammatory response to LPS in patients with decompensated cirrhosis.
Coant N; Simon-Rudler M; Gustot T; Fasseu M; Gandoura S; Ragot K; Abdel-Razek W; Thabut D; Lettéron P; Ogier-Denis E; Ouziel R; Devière J; Lizard G; Tellier Z; Lebrec D; Moreau R
J Hepatol; 2011 Oct; 55(4):784-93. PubMed ID: 21334395
[TBL] [Abstract][Full Text] [Related]
25. Glycogen synthase kinase-3beta inhibitors protect against the organ injury and dysfunction caused by hemorrhage and resuscitation.
Dugo L; Abdelrahman M; Murch O; Mazzon E; Cuzzocrea S; Thiemermann C
Shock; 2006 May; 25(5):485-91. PubMed ID: 16680013
[TBL] [Abstract][Full Text] [Related]
26. Cardioprotection by GSK-3 inhibition: role of enhanced glycogen synthesis and attenuation of calcium overload.
Omar MA; Wang L; Clanachan AS
Cardiovasc Res; 2010 Jun; 86(3):478-86. PubMed ID: 20053658
[TBL] [Abstract][Full Text] [Related]
27. Noninvasive magnetic resonance spectroscopic pharmacodynamic markers of the choline kinase inhibitor MN58b in human carcinoma models.
Al-Saffar NM; Troy H; Ramírez de Molina A; Jackson LE; Madhu B; Griffiths JR; Leach MO; Workman P; Lacal JC; Judson IR; Chung YL
Cancer Res; 2006 Jan; 66(1):427-34. PubMed ID: 16397258
[TBL] [Abstract][Full Text] [Related]
28. Regulation of Akt mRNA and protein levels by glycogen synthase kinase-3beta in adrenal chromaffin cells: effects of LiCl and SB216763.
Nemoto T; Kanai T; Yanagita T; Satoh S; Maruta T; Yoshikawa N; Kobayashi H; Wada A
Eur J Pharmacol; 2008 May; 586(1-3):82-9. PubMed ID: 18395711
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of GSK-3beta decreases NF-kappaB-dependent gene expression and impairs the rat liver regeneration.
Chen H; Yang S; Yang Z; Ma L; Jiang D; Mao J; Jiao B; Cai Z
J Cell Biochem; 2007 Dec; 102(5):1281-9. PubMed ID: 17427960
[TBL] [Abstract][Full Text] [Related]
30. Combination treatment of cancer cells with pan-Akt and pan-mTOR inhibitors: effects on cell cycle distribution, p-Akt expression level and radiolabelled-choline incorporation.
Phyu SM; Smith TAD
Invest New Drugs; 2019 Jun; 37(3):424-430. PubMed ID: 30056610
[TBL] [Abstract][Full Text] [Related]
31. Role of glycogen synthase kinase 3beta in rapamycin-mediated cell cycle regulation and chemosensitivity.
Dong J; Peng J; Zhang H; Mondesire WH; Jian W; Mills GB; Hung MC; Meric-Bernstam F
Cancer Res; 2005 Mar; 65(5):1961-72. PubMed ID: 15753396
[TBL] [Abstract][Full Text] [Related]
32. The supply of both CDP-choline and diacylglycerol can regulate the rate of phosphatidylcholine synthesis in HeLa cells.
Lim P; Cornell R; Vance DE
Biochem Cell Biol; 1986 Jul; 64(7):692-8. PubMed ID: 3756002
[TBL] [Abstract][Full Text] [Related]
33. Phosphatidylcholine biosynthesis in cultured glioma cells: evidence for channeling of intermediates.
George TP; Morash SC; Cook HW; Byers DM; Palmer FB; Spence MW
Biochim Biophys Acta; 1989 Aug; 1004(3):283-91. PubMed ID: 2758024
[TBL] [Abstract][Full Text] [Related]
34. Glycogen synthase kinase 3 inhibition slows mitochondrial adenine nucleotide transport and regulates voltage-dependent anion channel phosphorylation.
Das S; Wong R; Rajapakse N; Murphy E; Steenbergen C
Circ Res; 2008 Oct; 103(9):983-91. PubMed ID: 18802025
[TBL] [Abstract][Full Text] [Related]
35. Glycogen synthase kinase-3beta regulates differentiation-induced apoptosis of human neural progenitor cells.
Jaeger A; Baake J; Weiss DG; Kriehuber R
Int J Dev Neurosci; 2013 Feb; 31(1):61-8. PubMed ID: 23085082
[TBL] [Abstract][Full Text] [Related]
36. Design, synthesis, and evaluation of 3-aryl-4-pyrrolyl-maleimides as glycogen synthase kinase-3β inhibitors.
Ye Q; Li M; Zhou YB; Cao JY; Xu L; Li YJ; Han L; Gao JR; Hu YZ; Li J
Arch Pharm (Weinheim); 2013 May; 346(5):349-58. PubMed ID: 23585245
[TBL] [Abstract][Full Text] [Related]
37. Small-molecule GSK-3 inhibitor rescued apoptosis and neurodegeneration in anesthetics-injured dorsal root ganglion neurons.
Yu T; Lin W
Biomed Pharmacother; 2016 Dec; 84():395-402. PubMed ID: 27668540
[TBL] [Abstract][Full Text] [Related]
38. Constitutive activity of glycogen synthase kinase-3beta: positive regulation of steady-state levels of insulin receptor substrates-1 and -2 in adrenal chromaffin cells.
Nemoto T; Yokoo H; Satoh S; Yanagita T; Sugano T; Yoshikawa N; Maruta T; Kobayashi H; Wada A
Brain Res; 2006 Sep; 1110(1):1-12. PubMed ID: 16870161
[TBL] [Abstract][Full Text] [Related]
39. Glycogen synthase kinase-3beta/beta-catenin promotes angiogenic and anti-apoptotic signaling through the induction of VEGF, Bcl-2 and survivin expression in rat ischemic preconditioned myocardium.
Kaga S; Zhan L; Altaf E; Maulik N
J Mol Cell Cardiol; 2006 Jan; 40(1):138-47. PubMed ID: 16288908
[TBL] [Abstract][Full Text] [Related]
40. The effects of GSK-3β blockade on ketamine self-administration and relapse to drug-seeking behavior in rats.
Huang X; Huang K; Zheng W; Beveridge TJ; Yang S; Li X; Li P; Zhou W; Liu Y
Drug Alcohol Depend; 2015 Feb; 147():257-65. PubMed ID: 25497591
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
